FINWIRES · TerminalLIVE
FINWIRES

研究快訊:CFRA 將拉斯維加斯金沙集團股票評等從「持有」上調至「買入」。

-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點摘要如下:我們將LVS的12個月目標價調高2美元至65美元,基於我們2026年調整後EBITDA預期值的10.1倍,略高於該公司過去三年平均預期EV/EBITDA倍數9.7倍,且高於同業平均水準。我們認為,該公司值得獲得高於同業的估值倍數,這主要得益於其濱海灣金沙物業,該物業近年來業績顯著優於澳門和拉斯維加斯的賭場。鑑於強勁的業績表現以及年初至今股價20%的下跌,我們認為LVS的股票價值正在顯現。週四早盤交易中,LVS股價下跌超過8%,為投資者提供了以折扣買入股票的絕佳機會。我們相信,LVS擁有強大的物業組合,近年來業績表現優異。濱海灣金沙持續保持強勁勢頭,我們相信澳門也將緊跟其後,第一季營收成長24%,EBITDA成長18%。目前,該股股價低於未來12個月EBITDA預期值的9倍。

Related Articles

Asia

Easou Technology Invests $7.7 Million in Wealth Product Using Idle Top-up Placing Funds

Easou Technology (HKG:2550) said it has subscribed to a $7.7 million wealth management product issued by Huatai International Financial Products, using idle proceeds from its earlier placings, according to a Friday Hong Kong bourse filing.Shares of the digital service firm were down over 1% in Monday's late-morning trade.The investment, guaranteed by Huatai International Financial, carries an annualized return of 1.07% to 5.83% over a term ending March 30, 2027.Easou said the move aims to enhance the utilization efficiency and returns on idle funds while maintaining liquidity.

$HKG:2550
Asia

SSY Group Gets Chinese Regulatory Nod for Production, Registration of Two Products

SSY Group (HKG:2005) said it received Chinese regulatory approval to begin drug production and registration of its diltiazem hydrochloride in injection form, according to a Hong Kong bourse filing Monday.The drug is mainly used to treat a heart condition known as supraventricular tachycardia and the emergency treatment of abnormally high blood pressure during surgery.The firm's propranolol hydrochloride injection was also approved for production and registration by China's National Medical Products Administration.The product is mainly used to treat supraventricular tachyarrhythmias and ventricular arrhythmias.

$HKG:2005
Asia

Amplitude Energy Says Australian Retirement Trust Raises Stake

Amplitude Energy (ASX:AEL) said Australian Retirement Trust raised its stake in the firm to 6.3% as of Friday from 5.1% as of April 2, according to a Monday Australian bourse filing.Australian Retirement Trust now holds nearly 19 million votes in the firm.

$ASX:AEL